Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
American University of Beirut Medical Center
Beirut, Lebanon
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
National and Kapodistrian University of Athens
Athens, Greece
University of Toronto
Toronto, Canada
University of Cagliari
Cagliari, Italy
Children's Hospital of Philadelphia
Philadelphia, United States
University of California, San Francisco
San Francisco, United States
University of Ferrara
Ferrara, Italy
University of Milan
Milan, Italy
University of Turin
Turin, Italy
References
References (95)
- 1
Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
Calvaruso G, Vitrano A, Di Maggio R, et al.
American journal of hematology 2015; (90(7)):634-8 doi:10.1002/ajh.24024.
PMID: 25809173 - 2
Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.
Inthawong K, Charoenkwan P, Silvilairat S, et al.
Hematology (Amsterdam, Netherlands) 2015; (20(10)):610-7 doi:10.1179/1607845415Y.0000000014.
PMID: 25964094 - 3
Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.
Majd Z, Haghpanah S, Ajami GH, et al.
Iranian Red Crescent medical journal 2015; (17(4)):e24959 doi:10.5812/ircmj.17(4)2015.24959.
PMID: 26023341 - 4
Screening for common β-globin gene cluster deletions in Chinese individuals with increased hemoglobin F.
Cai WJ, Li J, Xie XM, Li DZ
International journal of laboratory hematology 2015; (37(6)):752-7 doi:10.1111/ijlh.12401.
PMID: 26179971 - 5
β-Thalassemia Intermedia Caused by Compound Heterozygosity for Hb Lepore-Hollandia and β-Thalassemia is Rare in the Indian Population.
Sreedharanunni S, Chhabra S, Hira JK, et al.
Hemoglobin 2015; (39(5)):362-5 doi:10.3109/03630269.2015.1064004.
PMID: 26291970 - 6
Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Current medical research and opinion 2016; (32(1)):191-204 doi:10.1185/03007995.2015.1110128.
PMID: 26479125 - 7
Increasing prevalence of thalassemia in America: Implications for primary care.
Sayani FA, Kwiatkowski JL
Annals of medicine 2015; (47(7)):592-604 doi:10.3109/07853890.2015.1091942.
PMID: 26541064 - 8
Hb lepore/β0-thalassaemia with α+-thalassaemia interactions, a potential diagnostic pitfall.
Alauddin H, Mohamad Nasir S, Ahadon M, et al.
The Malaysian journal of pathology 2015; (37(3)):287-92.
PMID: 26712677 - 9
Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.
Baronciani D, Angelucci E, Potschger U, et al.
Bone marrow transplantation 2016; (51(4)):536-41 doi:10.1038/bmt.2015.293.
PMID: 26752139 - 10
Corpuscular Haemolytic Anaemias - Lepore Haemoglobinopathy.
Tudorascu I, Neamtu S, Stanca L, et al.
Current health sciences journal 2014; (40(4)):281-4 doi:10.12865/CHSJ.40.04.10.
PMID: 26793325 - 11
Morbidities in non-transfusion-dependent thalassemia.
Saliba AN, Taher AT
Annals of the New York Academy of Sciences 2016; (1368(1)):82-94 doi:10.1111/nyas.13083.
PMID: 27186941 - 12
Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?
Coates TD, Carson S, Wood JC, Berdoukas V
Annals of the New York Academy of Sciences 2016; (1368(1)):95-106 doi:10.1111/nyas.13060.
PMID: 27186942 - 13
Medical complications following splenectomy.
Buzelé R, Barbier L, Sauvanet A, Fantin B
Journal of visceral surgery 2016; (153(4)):277-86.
PMID: 27289254 - 14
Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine.
Hassan MA, Tolba OA
Electronic physician 2016; (8(5)):2425-31 doi:10.19082/2425.
PMID: 27382454 - 15
Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study.
Chong J, Jones P, Spelman D, et al.
Epidemiology and infection 2017; (145(2)):397-400 doi:10.1017/S0950268816002405.
PMID: 27776576 - 16
Invasive prenatal diagnosis of fetal thalassemia.
Li DZ, Yang YD
Best practice & research. Clinical obstetrics & gynaecology 2017; (39()):41-52 doi:10.1016/j.bpobgyn.2016.10.011.
PMID: 27889305 - 17
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
Taher AT, Origa R, Perrotta S, et al.
American journal of hematology 2017; (92(5)):420-428 doi:10.1002/ajh.24668.
PMID: 28142202 - 18
Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy.
Ricchi P, Ammirabile M, Spasiano A, et al.
Hematology (Amsterdam, Netherlands) 2017; (22(7)):437-443 doi:10.1080/10245332.2017.1289304.
PMID: 28218017 - 19
Incomplete paraplegia caused by extramedullary hematopoiesis in a patient with thalassemia intermedia.
Hisamud-Din N, Mustafah NM, Fauzi AA, Hashim NM
Spinal cord series and cases 2017; (3()):17020 doi:10.1038/scsandc.2017.20.
PMID: 28503326 - 20
Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child.
Pirastru M, Manca L, Trova S, Mereu P
BioMed research international 2017; (2017()):1261972 doi:10.1155/2017/1261972.
PMID: 28553644 - 21
Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G, Orofino MG, Vacca A, et al.
American journal of hematology 2017; (92(12)):1303-1310 doi:10.1002/ajh.24898.
PMID: 28850704 - 22
Iron overload in thalassemia: different organs at different rates.
Taher AT, Saliba AN
Hematology. American Society of Hematology. Education Program 2017; (2017(1)):265-271 doi:10.1182/asheducation-2017.1.265.
PMID: 29222265 - 23
New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD, Motta I
Hematology. American Society of Hematology. Education Program 2017; (2017(1)):278-283 doi:10.1182/asheducation-2017.1.278.
PMID: 29222267 - 24
Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.
Bou-Fakhredin R, Bazarbachi AH, Chaya B, et al.
International journal of molecular sciences 2017; (18(12)) doi:10.3390/ijms18122778.
PMID: 29261151 - 25
Hydroxyurea for lifelong transfusion-dependent β-thalassemia: A meta-analysis.
Algiraigri AH, Wright NAM, Paolucci EO, Kassam A
Pediatric hematology and oncology 2017; (34(8)):435-448 doi:10.1080/08880018.2017.1354948.
PMID: 29337597 - 26
Vitamin D deficiency and its relationship with cardiac iron and function in patients with transfusion-dependent thalassemia at Chiang Mai University Hospital.
Dejkhamron P, Wejaphikul K, Mahatumarat T, et al.
Pediatric hematology and oncology 2018; (35(1)):52-59 doi:10.1080/08880018.2018.1424280.
PMID: 29359982 - 27
Molecular Characteristics of Hb New York [β113(G15)Val→Glu, HBB: c.341T>A] in Thailand.
Chaibunruang A, Singha K, Srivorakun H, et al.
Hemoglobin 2018; (42(1)):11-15 doi:10.1080/03630269.2018.1430586.
PMID: 29464999 - 28
Under-recognized Hypoparathyroidism in Thalassemia
Tangngam H, Mahachoklertwattana P, Poomthavorn P, et al.
Journal of clinical research in pediatric endocrinology 2018; (10(4)):324-330 doi:10.4274/jcrpe.0020.
PMID: 29726397 - 29
The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States.
Patel K, Bhivandkar S, Desai R, Antin T
Annals of hematology 2019; (98(4)):851-860 doi:10.1007/s00277-018-3557-5.
PMID: 30488326 - 30
Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
Ngim CF, Lee MY, Othman N, et al.
Hemoglobin 2019; (43(2)):95-100 doi:10.1080/03630269.2019.1599906.
PMID: 31179787 - 31
Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems.
De Sanctis V, Soliman AT, Canatan D, et al.
Mediterranean journal of hematology and infectious diseases 2019; (11(1)):e2019029 doi:10.4084/MJHID.2019.029.
PMID: 31205633 - 32
Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M, Bozorgi H, Saki F, et al.
Journal of endocrinological investigation 2019; (42(12)):1467-1476 doi:10.1007/s40618-019-01072-z.
PMID: 31228105 - 33
Challenges of blood transfusions in β-thalassemia.
Shah FT, Sayani F, Trompeter S, et al.
Blood reviews 2019; (37()):100588 doi:10.1016/j.blre.2019.100588.
PMID: 31324412 - 34
Thalassemia: Common Clinical Queries in Management.
Lal A, Bansal D
Indian journal of pediatrics 2020; (87(1)):75-81 doi:10.1007/s12098-019-03065-5.
PMID: 31620986 - 35
Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers.
Russo V, Melillo E, Papa AA, et al.
Cardiology research and practice 2019; (2019()):9319832 doi:10.1155/2019/9319832.
PMID: 31885907 - 36
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, et al.
The New England journal of medicine 2020; (382(13)):1219-1231 doi:10.1056/NEJMoa1910182.
PMID: 32212518 - 37
Complications in the adult asplenic patient: A review for the emergency clinician.
Long B, Koyfman A, Gottlieb M
The American journal of emergency medicine 2021; (44()):452-457 doi:10.1016/j.ajem.2020.03.049.
PMID: 32247651 - 38
For Debate: Assessment of HbA1c in Transfusion Dependent Thalassemia Patients.
De Sanctis V, Soliman AT, Daar S, et al.
Pediatric endocrinology reviews : PER 2020; (17(3)):226-234 doi:10.17458/per.vol17.2020.fd.ssd.HbA1cthalassemia.
PMID: 32741153 - 39
The Trabecular Bone Score as a Predictor for Thalassemia-Induced Vertebral Fractures in Northeastern Thailand.
Teawtrakul N, Chukanhom S, Charoensri S, et al.
Anemia 2020; (2020()):4634709 doi:10.1155/2020/4634709.
PMID: 32774916 - 40
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications.
Takhviji V, Zibara K, Azarkeivan A, et al.
Transfusion medicine (Oxford, England) 2020; (30(5)):352-360 doi:10.1111/tme.12707.
PMID: 32820581 - 41
Overwhelming Post-Splenectomy Infection Syndrome: Variability in Timing With Similar Presentation.
Gupta AK, Vazquez OA
Cureus 2020; (12(8)):e9914 doi:10.7759/cureus.9914.
PMID: 32968576 - 42
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.
Pistoia L, Meloni A, Ricchi P, et al.
Blood transfusion = Trasfusione del sangue 2021; (19(2)):168-176 doi:10.2450/2020.0023-20.
PMID: 33000750 - 43
Comparison of Two High-Pressure Liquid Chromatography Instruments Bio-Rad Variant-II and Tosoh HLC-723G11 in the Evaluation of Hemoglobinopathies.
Chopra P, Bhardwaj S, Negi P, Arora A
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2020; (36(4)):725-732 doi:10.1007/s12288-020-01298-5.
PMID: 33100717 - 44
Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.
Pinto VM, Forni GL
International journal of molecular sciences 2020; (21(22)) doi:10.3390/ijms21228771.
PMID: 33233561 - 45
The use of luspatercept for thalassemia in adults.
Cappellini MD, Taher AT
Blood advances 2021; (5(1)):326-333 doi:10.1182/bloodadvances.2020002725.
PMID: 33570654 - 46
Extramedullary Hematopoiesis Causing Spinal Cord Compression.
Judy BF, Jin Y, Sciubba DM
World neurosurgery 2021; (149()):51-52 doi:10.1016/j.wneu.2021.02.023.
PMID: 33601081 - 47
Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major.
Nuzzi R, Geronazzo G, Tridico F, et al.
Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):2099-2109 doi:10.2147/OPTH.S300974.
PMID: 34045846 - 48
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Porter J, Taher A, Viprakasit V, et al.
Expert review of hematology 2021; (14(7)):633-644 doi:10.1080/17474086.2021.1935854.
PMID: 34324404 - 49
Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia.
Khodashenas M, Mardi P, Taherzadeh-Ghahfarokhi N, et al.
Journal of environmental and public health 2021; (2021()):2849163 doi:10.1155/2021/2849163.
PMID: 34457009 - 50
Homozygous Hemoglobin Lepore: A Rare Condition Seen in a Bangladeshi Family.
Aziz MA, Khan WA, Das SA, Banu B
Mymensingh medical journal : MMJ 2021; (30(4)):1172-1176.
PMID: 34605493 - 51
Genetic and non-genetic factors affecting hemoglobin A2 expression in a large cohort of Thai individuals: implication for population screening for thalassemia.
Singha K, Sanchaisuriya K, Fucharoen G, Fucharoen S
American journal of translational research 2021; (13(10)):11632-11642.
PMID: 34786089 - 52
High prevalence of central hypothyroidism among patients with transfusion dependent thalassemia in Hospital Pulau Pinang: A cross sectional study.
Seow CE, Goh AS, Lim SL
The Medical journal of Malaysia 2021; (76(6)):799-803.
PMID: 34806663 - 53
Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
Bayraktaroglu S, Karadas N, Onen S, et al.
Annals of hematology 2022; (101(3)):521-529 doi:10.1007/s00277-021-04748-w.
PMID: 34985558 - 54
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.
Saad HKM, Abd Rahman AA, Ab Ghani AS, et al.
Biomedicines 2022; (10(1)) doi:10.3390/biomedicines10010189.
PMID: 35052868 - 55
A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.
Yasara N, Wickramarathne N, Mettananda C, et al.
Scientific reports 2022; (12(1)):2752 doi:10.1038/s41598-022-06774-8.
PMID: 35177777 - 56
Alpha- and Beta-thalassemia: Rapid Evidence Review.
Baird DC, Batten SH, Sparks SK
American family physician 2022; (105(3)):272-280.
PMID: 35289581 - 57
[Clinical Diagnosis and Prenatal Screening of Hb Lepore-BW Associated with IVS-II-654 Heterozygous Mutation].
Bai HL, Cheng W, Cui J, et al.
Zhongguo shi yan xue ye xue za zhi 2022; (30(2)):529-533 doi:10.19746/j.cnki.issn.1009-2137.2022.02.034.
PMID: 35395991 - 58
Prevalence and risk factors of fractures in transfusion dependent thalassemia - A Hong Kong Chinese population cohort.
Lee SLK, Wong RSM, Li CK, Leung WK
Endocrinology, diabetes & metabolism 2022; (5(4)):e340 doi:10.1002/edm2.340.
PMID: 35490138 - 59
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.
Farmakis D, Porter J, Taher A, et al.
HemaSphere 2022; (6(8)):e732 doi:10.1097/HS9.0000000000000732.
PMID: 35928543 - 60
Homozygous Lepore Syndrome: A case report.
Bhusal A, Bhandari S, Seth T, Sah RP
Annals of medicine and surgery (2012) 2022; (80()):104168 doi:10.1016/j.amsu.2022.104168.
PMID: 36045803 - 61
Thalassemia Intermedia: Chelator or Not?
Lee YC, Yen CT, Lee YL, Chen RJ
International journal of molecular sciences 2022; (23(17)) doi:10.3390/ijms231710189.
PMID: 36077584 - 62
Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective.
Knoth RL, Gupta S, Perkowski K, et al.
Journal of clinical medicine 2023; (12(2)) doi:10.3390/jcm12020414.
PMID: 36675342 - 63
Identification of rare thalassemia variants using third-generation sequencing.
Liu Q, Chen Q, Zhang Z, et al.
Frontiers in genetics 2022; (13()):1076035 doi:10.3389/fgene.2022.1076035.
PMID: 36685902 - 64
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia.
Sayani FA, Singer ST, Carlberg KT, Vichinsky EP
Hematology/oncology clinics of North America 2023; (37(2)):393-411 doi:10.1016/j.hoc.2022.12.008.
PMID: 36907611 - 65
Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies.
Radauer-Plank AC, Diesch-Furlanetto T, Schneider M, et al.
Pediatric blood & cancer 2023; (70(7)):e30359 doi:10.1002/pbc.30359.
PMID: 37057367 - 66
Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy.
Musallam KM, Taher AT, Kattamis A, et al.
Drug design, development and therapy 2023; (17()):1583-1591 doi:10.2147/DDDT.S368584.
PMID: 37255740 - 67
Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START).
Elalfy MS, Hamdy M, Adly A, et al.
American journal of hematology 2023; (98(9)):1415-1424 doi:10.1002/ajh.27010.
PMID: 37401738 - 68
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
Ontario health technology assessment series 2023; (23(4)):1-398.
PMID: 37637488 - 69
Rare occurrence of hemoglobin Lepore variant in a Palestinian patient: a case report and brief literature review.
Asees MY, Shrateh ON, Jobran AWM, Assi AS
Annals of medicine and surgery (2012) 2023; (85(10)):5219-5222 doi:10.1097/MS9.0000000000001212.
PMID: 37811104 - 70
Severe iron overload cardiomyopathy manifested as acute myopericarditis: A case report.
Kosum P, Theerasuwipakorn N, Wicheantawatchai A, et al.
Radiology case reports 2024; (19(1)):290-295 doi:10.1016/j.radcr.2023.10.020.
PMID: 38028286 - 71
Identification of Hb Lepore, Hb anti-Lepore, and α-globin gene triplications by long-read single-molecule real-time sequencing.
Xu A, Ye Y, Huang Y, et al.
American journal of clinical pathology 2024; (161(4)):411-417 doi:10.1093/ajcp/aqad155.
PMID: 38037185 - 72
Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis.
Vlachodimitropoulou E, Mogharbel H, Kuo KHM, et al.
Blood advances 2024; (8(3)):746-757 doi:10.1182/bloodadvances.2023011636.
PMID: 38181780 - 73
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study.
Musallam KM, Barella S, Origa R, et al.
Annals of hematology 2024; (103(7)):2283-2297 doi:10.1007/s00277-024-05715-x.
PMID: 38503936 - 74
Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.
Drahos J, Boateng-Kuffour A, Calvert M, et al.
The patient 2024; (17(4)):421-439 doi:10.1007/s40271-024-00678-7.
PMID: 38530509 - 75
Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing.
Zhuang J, Zhang N, Zheng Y, et al.
Scientific reports 2024; (14(1)):9966 doi:10.1038/s41598-024-60604-7.
PMID: 38693200 - 76
Compound heterozygous with Hb G-Taipei and Hb Lepore-Boston-Washington: An unexpected finding triggered by HbA1c measurement.
Li Y, Xu A, He J, et al.
Practical laboratory medicine 2024; (39()):e00379 doi:10.1016/j.plabm.2024.e00379.
PMID: 38715657 - 77
Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia.
Ananvutisombat N, Tantiworawit A, Punnachet T, et al.
Frontiers in endocrinology 2024; (15()):1393865 doi:10.3389/fendo.2024.1393865.
PMID: 38978629 - 78
The Relevance of β-Thalassemia Heterozygosity in Pediatric Clinical Practice: Croatian Experience.
Dordevic A, Ugrin M, Sutic IM, et al.
Children (Basel, Switzerland) 2024; (11(7)) doi:10.3390/children11070785.
PMID: 39062234 - 79
Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel.
Mirza A, Ritsert ML, Tao G, et al.
Blood advances 2025; (9(1)):29-38 doi:10.1182/bloodadvances.2024014104.
PMID: 39418614 - 80
Epidural Spinal Cord Compression due to Extramedullary Hematopoiesis: Systematic Review of the Literature with an Illustrative Case.
Lam NG, Ahmadpour A, Gimelfarb A, et al.
World neurosurgery 2025; (193()):119-130 doi:10.1016/j.wneu.2024.10.034.
PMID: 39427876 - 81
Estimation of HbA1c Levels in Transfusion-Dependent Thalassemia Patients in Comparison With Normal Healthy Individuals.
Bhatti PK, Ghay R, Singh Narang G, et al.
Cureus 2024; (16(11)):e73236 doi:10.7759/cureus.73236.
PMID: 39651019 - 82
Long-term complications, survival and mortality in splenectomised adult transfusion-dependent thalassemia patients.
Bhattacharjee U, Khadwal A, Singh C, et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2025; (64(1)):104064 doi:10.1016/j.transci.2024.104064.
PMID: 39787843 - 83
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.
de Sanctis V, Canatan D, Daar S, et al.
Mediterranean journal of hematology and infectious diseases 2025; (17(1)):e2025008 doi:10.4084/MJHID.2025.008.
PMID: 39830799 - 84
International Consensus Guideline on the Diagnosis and Management of Endocrine Complications of β and α Thalassemia in Children and Adolescents.
Habeb A, Deeb A, Hamza RT, et al.
Hormone research in paediatrics 2026; (99(7)):931-954 doi:10.1159/000546904.
PMID: 40555215 - 85
Beyond the blood: A practical guide to thalassemia care in the emergency department.
Mufarrij A, Hodroj MH, Charbel N, et al.
Blood reviews 2025; (74()):101327 doi:10.1016/j.blre.2025.101327.
PMID: 40769855 - 86
Endocrine dysfunction in homozygous beta-thalassemia: An underrecognized and undertreated consequence of prolonged survival.
Savvidis C, Ilias I
World journal of clinical cases 2025; (13(24)):107612 doi:10.12998/wjcc.v13.i24.107612.
PMID: 40862198 - 87
Novel Red Blood Cell Exchange Parameters for Treatment of Transfusion-Dependent Thalassemia Based on Experience of Five Patients.
Sevcik K, Jackson C, Williams SM, et al.
Journal of hematology 2025; (14(4)):210-213 doi:10.14740/jh2086.
PMID: 40904934 - 88
Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion Support.
Inam Z, Han H, Webb J, Delaney M
Transfusion medicine reviews 2025; (39(4)):150930 doi:10.1016/j.tmrv.2025.150930.
PMID: 41223813 - 89
A multi-center clinical trial of allogeneic hematopoietic stem cell transplantation in transfusion-dependent thalassemia.
Liu R, Xiao H, Qin C, et al.
Nature communications 2026; (17(1)).
PMID: 41730859 - 90
Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.
Testa U, Castelli G, Pelosi E
Journal of clinical medicine 2026; (15(4)) doi:10.3390/jcm15041379.
PMID: 41753067 - 91
Current therapeutic landscape of β-thalassemia: focus on gene therapy.
Cheng AN, Kwiatkowski JL
Therapeutic advances in rare disease 2026; (7()):26330040261433028 doi:10.1177/26330040261433028.
PMID: 41919270 - 92
Overwhelming Post-Splenectomy Infection: A Case Report With Cause and Manner of Death Considerations.
Newman JL, Gilson TP
Academic forensic pathology 2026; 19253621261460506 doi:10.1177/19253621261460506.
PMID: 42317492 - 93
Diagnosis and Management of Transfusion-Dependent Thalassemia: Evidence-Based Guidelines From the Pediatric Hematology Oncology Chapter of the Indian Academy of Pediatrics.
Radhakrishnan N, Dewan P, Chandra J, et al.
Indian pediatrics 2026; (63(9)):612-637 doi:10.1007/s13312-026-00366-9.
PMID: 42490030 - 94
Precision Medicine in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia: Toward Personalized Diagnosis and Therapy.
Karen AA, Tluli O, Hashem IE, et al.
Hemoglobin 2026; (50(5)):405-413 doi:10.1080/03630269.2026.2709700.
PMID: 42572810 - 95
Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges.
Delicou S, Xydaki A, Moraki M, et al.
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) 2026; (8(4)):406-416 doi:10.1097/FM9.0000000000000353.
PMID: 42936835